Placebo surgery research: A blinding imperative

被引:16
作者
Heckerling, Paul S. [1 ]
机构
[1] Univ Illinois, Dept Med, Chicago, IL 60612 USA
关键词
placebo surgery; sham surgery; blinding; masking; ethics; human research;
D O I
10.1016/j.jclinepi.2006.03.001
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In placebo surgery research, intervention group subjects receive a real surgical procedure, and control subjects receive a sham surgical procedure. The sham procedure is designed to recapitulate enough of the real procedure to blind participants to group assignment. Placebo surgery designs are used to control for placebo effects, and to eliminate the bias that might result if participants and investigators were aware of group assignment when outcomes are measured. In placebo surgery studies, in which participants are placed at increased risk to achieve the scientific validity provided by blinding, it is imperative that the blind be maintained, and maintainable, to justify putting subjects at risk to achieve it. In circumstances in which the outcome assessors are not fully blinded, or in which the intervention is not amenable to rigorous blinding, placebo surgery studies are not ethical. Investigators doing placebo surgery trials should obtain data on the integrity of the blind from both subjects and outcome assessors, to inform the validity of the results and to provide input for "blindability" decisions involving future trials. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:876 / 880
页数:5
相关论文
共 30 条
[1]   Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls [J].
Albin, RL .
JOURNAL OF MEDICAL ETHICS, 2002, 28 (05) :324-327
[2]   A review of blinding in randomized controlled trials found results inconsistent and questionable [J].
Boutron, I ;
Estellat, C ;
Ravaud, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (12) :1220-1226
[3]   Placebo surgery for Parkinson's disease: Do the benefits outweigh the risks? [J].
Clark, PA .
JOURNAL OF LAW MEDICINE & ETHICS, 2002, 30 (01) :58-+
[4]   Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope - Second Vasovagal Pacemaker Study (VPS II): A randomized trial [J].
Connolly, SJ ;
Sheldon, R ;
Thorpe, KE ;
Roberts, RS ;
Ellenbogen, KA ;
Wilkoff, BL ;
Morillo, C ;
Gent, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (17) :2224-2229
[5]  
DICK JSB, 2001, RETINA, P967
[6]   What makes clinical research ethical? [J].
Emanuel, EJ ;
Wendler, D ;
Grady, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20) :2701-2711
[7]   Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials [J].
Fergusson, D ;
Glass, KC ;
Waring, D ;
Shapiro, S .
BRITISH MEDICAL JOURNAL, 2004, 328 (7437) :432-434
[8]   Transplantation of embryonic dopamine neurons for severe Parkinson's disease. [J].
Freed, CR ;
Greene, PE ;
Breeze, RE ;
Tsai, WY ;
DuMouchel, W ;
Kao, R ;
Dillon, S ;
Winfield, H ;
Culver, S ;
Trojanowski, JQ ;
Eidelberg, D ;
Fahn, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :710-719
[9]   Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease [J].
Freeman, TB ;
Vawter, DE ;
Leaverton, PE ;
Godbold, JH ;
Hauser, RA ;
Goetz, CG ;
Olanow, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (13) :988-992
[10]   Splinting vs surgery in the treatment of carpal tunnel syndrome - A randomized controlled trial [J].
Gerritsen, AAM ;
de Vet, HCW ;
Scholten, RJPM ;
Bertelsmann, FW ;
de Krom, MCTFM ;
Bouter, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (10) :1245-1251